Eli Lilly reportedly has awarded $250 million in planning work for brands including Cialis, Evista, Humalog, Effient and Byetta to Omnicom Group's OMD, without a review. OMD, which already reps Lilly's media buying, has ended its relationship with big pharma rival Schering Plough because of the Lilly account, according to this article.

Full Story:

Related Summaries